Inventor
AUSTAD BRIAN C
US19 patents
⚠️ This page may combine multiple inventors who share the name “AUSTAD BRIAN C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KARYOPHARM THERAPEUTICS INC
7 patentsUS11078190B2Aug 3, 2021
Polymorphs of selinexor
KARYOPHARM THERAPEUTICS INC11 citations93
US10519139B2Dec 31, 2019
Polymorphs of Selinexor
KARYOPHARM THERAPEUTICS INC17 citations93
US11807629B2Nov 7, 2023
Polymorphs of Selinexor
KARYOPHARM THERAPEUTICS INC6 citations85
US11753401B2Sep 12, 2023
Polymorphs of Selinexor
KARYOPHARM THERAPEUTICS INC5 citations85
US11746102B2Sep 5, 2023
Polymorphs of selinexor
KARYOPHARM THERAPEUTICS INC5 citations85
US12371420B2Jul 29, 2025
Polymorphs of Selinexor
KARYOPHARM THERAPEUTICS INC1 citations74
US12479806B2Nov 25, 2025
Process for preparing XPO1 inhibitors and intermediates for use in the preparation of XPO1 inhibitors
KARYOPHARM THERAPEUTICS INC0 citations51
INFINITY PHARMACEUTICALS INC
5 patentsUS9238672B2Jan 19, 2016
Methods for stereoselective reduction
INFINITY PHARMACEUTICALS INC14 citations84
US9879025B2Jan 30, 2018
Transfer hydrogenation of cyclopamine analogs
INFINITY PHARMACEUTICALS INC3 citations71
US9879293B2Jan 30, 2018
Enzymatic transamination of cyclopamine analogs
INFINITY PHARMACEUTICALS INC3 citations68
US7947670B2May 24, 2011
Ansamycin formulations and methods of use thereof
INFINITY PHARMACEUTICALS INC3 citations62
US9951089B2Apr 24, 2018
Methods of treating a fatty acid amide hydrolase-mediated condition
INFINITY PHARMACEUTICALS INC0 citations50
AUSTAD BRIAN C
4 patentsUS8716479B2May 6, 2014
Methods for stereoselective reduction
AUSTAD BRIAN C19 citations91
US8703448B2Apr 22, 2014
Enzymatic transamination of cyclopamine analogs
AUSTAD BRIAN C19 citations87
US8283343B2Oct 9, 2012
Ansamycin formulations and methods of use thereof
AUSTAD BRIAN C0 citations51
US9034849B2May 19, 2015
Fatty acid amide hydrolase inhibitors
AUSTAD BRIAN C0 citations49